TScan Therapeutics Company
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Connections from
Funding Status:
IPO
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2018-01-01
Employee Number:
51-100
Last Funding Type:
Series C
Total Funding:
137500000
Industry:
PharmTech